Melatonin provides signal 3 to unprimed CD4⁺ T cells but failed to stimulate LPS primed B cells

Abstract

Growing evidence has supported the conclusion that melatonin, a pineal hormone, modulates the immune function. In our previous study, we evaluated in vivo the potential role of melatonin in the regulation of the antigen specific T and B cells. In the present study, we observe that melatonin down-regulated the expression of the co-stimulatory molecule B7-1 but not B7-2 on macrophages. Further, melatonin encouraged the proliferation of anti-CD3 antibody activated CD4⁺ T cells only in the presence of antigen-presenting cells and promoted the production of Th2-like cytokines. Furthermore, it failed to influence the activity of B cells in a T-independent manner. Melatonin suppressed the release of TNF-α by LPS or IFN-γ activated macrophages but failed to inhibit Nitric Oxide (NO) release. Thus the study shows that melatonin can engineer the growth of unprimed CD4⁺ T cells if both the signals are provided by antigen-presenting cells. However, it could not regulate the function of B cells.